Skip to main content

Incontinence

2
Pipeline Programs
8
Companies
8
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Norgine
NorgineAustria - Vienna
1 program
1
NRL001Phase 11 trial
Active Trials
NCT00850590Completed48
TheraVida
TheraVidaNC - Chapel Hill
1 program
1
TolterodinePhase 11 trial
Active Trials
NCT01036035Completed18Est. Apr 2010
Coloplast
ColoplastAustralia - Mulgrave
1 program
BiofeedbackN/A1 trial
Active Trials
NCT00653887Terminated24Est. Dec 2009
Pelvital
PelvitalMN - Minneapolis
1 program
Pelvital probeN/A1 trial
Active Trials
NCT02954042Completed120Est. Oct 2019
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Telehealth interventionN/A1 trial
Active Trials
NCT06679621Recruiting357Est. Jun 2027
Zoll
ZollCA - San Jose
1 program
UroCoolN/A1 trial
Active Trials
NCT01920035Completed200Est. Dec 2014
Astellas
AstellasChina - Shenyang
1 program
VesicareN/A1 trial
Active Trials
NCT00581061Terminated13Est. Feb 2010
T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
lower urinary tract dysfunctionN/A1 trial
Active Trials
NCT02030340UnknownEst. Dec 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
TheraVidaTolterodine
NorgineNRL001
Human BioSciencesTelehealth intervention
PelvitalPelvital probe
T-Therapeuticslower urinary tract dysfunction
ZollUroCool
AstellasVesicare
ColoplastBiofeedback

Clinical Trials (8)

Total enrollment: 780 patients across 8 trials

NCT01036035TheraVidaTolterodine

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

Start: Sep 2009Est. completion: Apr 201018 patients
Phase 1Completed
NCT00850590NorgineNRL001

Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights

Start: Feb 200948 patients
Phase 1Completed
NCT06679621Human BioSciencesTelehealth intervention

A Telehealth Intervention to Increase Patient Preparedness for Surgery in Latinas

Start: Nov 2024Est. completion: Jun 2027357 patients
N/ARecruiting
NCT02954042PelvitalPelvital probe

Pelvital Stress Urinary Incontinence Training Device: P-SUIT

Start: Mar 2017Est. completion: Oct 2019120 patients
N/ACompleted
NCT02030340T-Therapeuticslower urinary tract dysfunction

Comparison of Air Charged Catheters With Water Filled Catheters for Urodynamic Study

Start: Dec 2013Est. completion: Dec 2014
N/AUnknown
NCT01920035ZollUroCool

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

Start: May 2013Est. completion: Dec 2014200 patients
N/ACompleted
NCT00581061AstellasVesicare

Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy

Start: Jun 2008Est. completion: Feb 201013 patients
N/ATerminated
NCT00653887ColoplastBiofeedback

Biofeedback and Cortical Excitability

Start: Jan 2008Est. completion: Dec 200924 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 780 patients
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.